Several studies have demonstrated that recombinant human soluble thrombomodulin (rhTM) has potential advantages for the treatment for patients with infection complicated by disseminated intravascular coagulation (DIC). However, whether injection of rhTMc
Several studies have demonstrated thatRecombinanthuman soluble thrombomodulin (rhTM) has potential advantages for the treatment for patients with infection complicated by disseminated intravascular coagulation (DIC).However, whether injection of rhTMcan affect themortality of those patients in clinical treatment remains controversial.Therefore, we conducted ameta-analysis to evaluate the clinical efficacy for patientswith infection complicated by DIC.
copyright©醫學論壇網 版權所有,未經許可不得複製、轉載或鏡像
京ICP證120392號 京公網安備110105007198 京ICP備10215607號-1 (京)網藥械信息備字(2022)第00160號